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macrophages improve plaque stability while pro-inflammatory macrophages 
promote rupture. Current evidence suggests a variety of macrophage 
phenotypes occur in atherosclerotic plaques with local lipids, cytokines, 
oxidised phospholipids and pathogenic stimuli altering their phenotype. 
In this study, we addressed differential functioning of macrophage 
phenotypes via a systematic analysis of in vitro polarised, human 
monocyte-derived macrophage phenotypes, focussing on molecular events 
that regulate foam-cell formation.  
Methods: We examined transcriptomes, protein levels and functionally 
determined lipid handling and foam cell formation capacity in macrophages 
polarised with IFNγ+LPS, IL-4, IL-10, oxPAPC and CXCL4.  
Results: RNA sequencing of differentially polarised macrophages revealed 
distinct gene expression changes, with enrichment in atherosclerosis and 
lipid-associated pathways. Analysis of lipid processing activity showed 
IL-4 and IL-10 macrophages have higher lipid uptake and foam cell 
formation activities, while inflammatory and oxPAPC macrophages displayed 
lower foam cell formation. Inflammatory macrophages showed low lipid 
uptake, while higher lipid uptake in oxPAPC macrophages was matched by 
increased lipid efflux capacity. 
Conclusions: Atherosclerosis-associated macrophage polarisation 
dramatically affects lipid handling capacity underpinned by major 
transcriptomic changes and altered protein levels in lipid-handling gene 
expression. This leads to phenotype-specific differences in LDL uptake, 
cellular cholesterol levels and cholesterol efflux, informing how the 
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Macrophage polarisation & lipid handling capacity 
Highlights: 
 
• Total RNA sequencing of differentially polarised macrophages showed 
enrichment in genes associated with atherosclerosis and lipid pathways  
• Anti-inflammatory macrophages had higher lipid uptake and foam cell formation 
activities 
• Inflammatory and oxPAPC macrophages displayed lower foam cell formation  
• Inflammatory macrophages showed low lipid uptake, while higher lipid uptake 










































































modified LDL reduced gene expression*
increased gene expression*
N – nucleus 
LE – late endosome
ER – endoplasmic reticulum
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(ii) Abstract  
Background & Aims: Lipid-rich foam cell macrophages drive atherosclerosis via several mechanisms, 
including inflammation, lipid uptake, lipid deposition and plaque vulnerability. The atheroma 
environment shapes macrophage function and phenotype; anti-inflammatory macrophages improve 
plaque stability while pro-inflammatory macrophages promote rupture. Current evidence suggests a 
variety of macrophage phenotypes occur in atherosclerotic plaques with local lipids, cytokines, 
oxidised phospholipids and pathogenic stimuli altering their phenotype. In this study, we addressed 
differential functioning of macrophage phenotypes via a systematic analysis of in vitro polarised, 
human monocyte-derived macrophage phenotypes, focussing on molecular events that regulate foam-
cell formation.  
Methods: We examined transcriptomes, protein levels and functionally determined lipid handling and 
foam cell formation capacity in macrophages polarised with IFNγ+LPS, IL–4, IL–10, oxPAPC and 
CXCL4.  
Results: RNA sequencing of differentially polarised macrophages revealed distinct gene expression 
changes, with enrichment in atherosclerosis and lipid-associated pathways. Analysis of lipid 
processing activity showed IL–4 and IL–10 macrophages have higher lipid uptake and foam cell 
formation activities, while inflammatory and oxPAPC macrophages displayed lower foam cell 
formation. Inflammatory macrophages showed low lipid uptake, while higher lipid uptake in oxPAPC 
macrophages was matched by increased lipid efflux capacity. 
Conclusions: Atherosclerosis-associated macrophage polarisation dramatically affects lipid handling 
capacity underpinned by major transcriptomic changes and altered protein levels in lipid-handling gene 
expression. This leads to phenotype-specific differences in LDL uptake, cellular cholesterol levels and 
cholesterol efflux, informing how the plaque environment influences atherosclerosis progression by 





































































Arterial macrophages form disease-associated lipid-rich foam cells in atherosclerotic plaques [1]. 
Progressive atherosclerosis results in cardiovascular diseases, which are a leading cause of death, 
worldwide [2]. Plaque formation arises from the accumulation of lipid in the artery wall over decades; 
acute myocardial infarction or stroke can occur following a loss of plaque stability due to cellular 
changes in the artery wall [3]. Macrophages are a predominant cell type within the artery wall, whose 
major functions in the plaque are to regulate inflammation, clear apoptotic cells via efferocytosis, 
regulate plaque stability by secreting matrix metalloproteases (MMPs) or protease inhibitors and to 
uptake, process, accumulate and efflux lipid [4]. The capacity of macrophages to accumulate or process 
lipid and to regulate proteases and cytokines in their local environment is a critical determinant of 
plaque development, lipid core formation and plaque stability [5,6]. 
 
Macrophages regulate lipoproteins within their local environment [7]. Uptake of lipoproteins occurs 
via receptor-mediated endocytosis, such as scavenger receptor, pinocytosis and phagocytosis [4]. 
Macrophages express scavenger receptors including SR-A1, CD36 and LOX-1 for lipoprotein uptake 
[8], while phagocytosis mediated internalisation delivers lipids to late endolysosomes where lysosomal 
acid lipase (LAL) digests cholesteryl esters to produce free cholesterol [9]. In the case of lipoprotein, 
cellular lipases such as LAL break down the lipoprotein particles that have been taken up, to 
cholesterol, triglycerides and fatty acids [10–12]. Cholesteryl esters and acylglycerides can be stored 
in lipid droplets, resulting in foam cell formation. Alternatively, Neutral cholesterol ester hydrolase 
(NCEH1) can metabolise these molecules into free cholesterol [13–15]; this can be removed from the 
cell by efflux or converted to fatty acids (oxidised to produce ATP) and glycerol [14,15]. Sterol O-
acyltransferase 1 (SOAT1) in the endoplasmic reticulum can re-esterify free cholesterol into 
cholesterol ester or fatty acids into acylglycerides, for subsequent storage in lipid droplets [4,16–18]. 
Cholesterol, produced by NCEH1, is then effluxed from the cell by transporters ABCA1, ABCG1 and 
SR-BI [19] or re-esterified and stored as lipid droplets [19]. The build-up of cellular cholesterol 
activates transcription factors RXR, LXRa, LXRb, PPARa and PPARg [20]. Heterodimerisation of 
LXR and RXR increases protein levels of ABCA1 and ABCG1, which actively transport HDL loaded-
cholesterol out of the cell [19]. The cytosolic accumulation of esterified cholesterol and acylglyceride 
droplets in macrophages results in the generation of foam cells, driving atherosclerotic plaque 
formation [9]. In addition to lipid uptake and intracellular processing, lipid and cholesterol content are 
influenced by the cellular capacity for cholesterol efflux. These efflux pathways in macrophages 
function to remove excess lipid to prevent its accumulation, which can be cytotoxic [21–23]. 
 
The local cellular environment determines macrophage function and phenotype [24]. Traditionally, 
macrophages have been described as classically activated M1 and alternatively activated M2 
macrophages [24]. Pro-inflammatory M1 macrophages arise from exposure to bacterial LPS and 
interferon-gamma [25]. Cytokines such as IL-4 and IL-13 drive polarisation to M2 macrophages [26]. 
In arterial atherosclerotic plaques, pro-inflammatory macrophages localise to areas of increased 
vulnerability, such as the shoulder regions[27]. In these vulnerable areas, they promote rupture by 
secreting MMPs and inflammatory cytokines thus weakening the cap structure [27]. In contrast, anti-
inflammatory macrophages are associated with increased plaque stability, at times with plaque 
regression and less severe disease [1]. The traditional classification of M1 and M2 macrophages is 
now widely understood to be simplistic where other “intermediate” or differently polarised phenotypes 
exist according to the local environment [25]. Macrophages expressing markers for both M1 and M2 



































































oxidised phospholipid [28], platelet-derived CXCL4 [29] and IL-10 [26] as well as haemoglobin [30], 
which can each influence macrophages to polarise to different functional states. 
 
The accumulation of lipid within the macrophage, and propensity to form foam cells, is altered 
according to macrophage phenotype [31]. Pro-inflammatory stimuli have been reported to alter 
expression of some scavenger receptors [32] [33] and to reduce cholesterol efflux transporter 
expression [34], reducing their capacity to clear lipid from the plaque. In contrast, IL-4 macrophages 
are considered to have high lipid handling and foam cell formation capacities [35]. The effect of IL-
10, CXCL4 and oxidised phospholipid on human macrophage lipid handling is less well understood.  
 
Compelling evidence shows that a variety of macrophage phenotypes occur in atherosclerotic plaques 
dependent on their environment. However, it is noteworthy that the majority of our current 
understanding of macrophage polarisation and its impact on atherosclerosis derives from murine 
models of atherosclerosis and analysis of mouse bone marrow derived macrophages [36,37]. The 
relevance to some of these findings to atherogenesis in humans is less clear. For example, whilst Nos2 
and Arg1 expression are robust markers of proinflammatory vs. alternatively activated macrophages, 
expression of these genes does not correlate with such macrophage subsets in humans [38–40]. In 
order to address how the variety of plaque macrophage phenotypes function differentially, we 
undertook a systematic study to model human macrophages polarised towards factors relevant to the 
atherosclerotic plaque environment. Using human samples, we sequenced and analysed whole 
transcriptomes, protein levels and functionally determined lipid handling and foam cell formation 
capacity in human macrophages polarised with IFNγ+LPS, IL–4, IL–10, oxPAPC (oxidised 
phospholipid 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine macrophages) and CXCL4. 
Our data revealed transcriptionally distinct phenotypes, differential lipid uptake, processing and efflux 
capacities and functional differences to account for low foam cell formation in differentially polarised 
inflammatory macrophages. 
 
2. Materials and methods 
Detailed methods are described in supplementary information. In brief, peripheral blood mononuclear 
cells (PBMCs) were isolated from whole blood donated by healthy adult donors and monocytes 
purified by CD14 positive magnetic selection. Monocytes were differentiated into monocyte–derived 
macrophages (MDMs) over 7 days in M–CSF, resulting in CD68+ macrophages expressing receptors 
for polarising agents (Supplementary methods; Supplementary Table 1). On day 7, the media was 
replaced for 24 h with fresh complete media containing the following polarising agents: IFNγ and LPS 
(R515); IL–4; IL–10; oxPAPC; CXCL4; or unpolarised as controls in each experiment (Supp.Fig.1). 
RNA was extracted from unpolarised and polarised MDM from 8 separate donors for RNA-seq 
analysis. RNA-seq data is deposited at DOI: 10.17632/j2hmt7k9fh.1. Differential gene expression was 
validated by qPCR, and protein by immunofluorescence and flow cytometry. Functional changes in 
foam cell formation and lipid handling were assessed by oil-red-o lipid staining, acLDL uptake, 




Polarisation causes atherosclerosis–related changes in MDM transcriptomes 
We set out to systematically extend the current knowledge of transcriptional changes associated with 



































































phenotypes arising from the same donors, treated under a variety of conditions reflecting the arterial 
plaque environment. Monocyte-derived macrophages from 8 donors were polarised with IFNγ+LPS, 
IL–4, IL–10, oxPAPC or CXCL4 and examined by RNA–seq for global and specific pathway changes 
in their transcriptomes that may influence atherosclerosis progression.  
Principal component analysis (PCA) clearly showed MIFNγ+LPS as the most transcriptionally 
distinct phenotype with > 5,500 differentially expressed genes (DEGs) compared to unpolarised 
macrophages and to other phenotypes (Figure 1A). MIFNγ+LPS displayed unique and high upregulation 
of common pro-inflammatory markers (Supplementary Tables 2 and 3). MIL–4 was the next most 
transcriptionally distinct phenotype as evidenced by the PCA, and characterised by IRF4 (interferon 
regulatory factor 4) and MRC1 (mannose receptor C–type 1) upregulation. The PCA shows that 
MIFNγ+LPS and MIL–4 represent the extreme ends of the in vitro MDM polarisation spectrum, since they 
exhibited the highest number of differentially expressed genes amongst the polarisation conditions 
applied. Interestingly, in the PCA MIL–10, MoxPAPC and MCXCL4 clustered more closely to unpolarised 
macrophages. Of note, MIL–10, MoxPAPC and MCXCL4 also showed a cytokine/chemokine (and their 
regulators) expression profile, similar to MIL–4. These included a notably lower upregulation of CXCL8 
(IL–8), CXCL9, CXCL11, IL1B, IL2RA and SOCS3 compared to MIFNγ+LPS, but no changes in IRF1, 
NFKB1, NFKB2, RELA and RELB expression (Supplementary Table 4). MIL–10 showed upregulation 
of CD163 RNA, consistent with recent findings [41], while MoxPAPC was clearly distinguished by 
increased RNA for HMOX1 (heme oxygenase 1) and TXNRD1 (thioredoxin reductase 1).  
CXCL4 macrophages showed a remarkably similar transcriptome profile to unpolarised 
macrophages as indicated by their close clustering in PCA and only 207 DEGs (1.53% of transcripts 
detected from a total of 13,531 genes) between the two conditions (Figure 1B). These results were 
largely in agreement with transcriptomic data on human monocyte-derived macrophages with and 
without CXCL4 polarisation from another study[42], where monocyte differentiation into unpolarised 
macrophages and MCXCL4 with M–CSF or CXCL4 respectively over 6 days resulted in only 460 
differentially expressed probes or 375 DEGs (1.77% out of 26,051 probes with signals above the 
detection limit [42]). S100A8 (S100 calcium binding protein A8) and MMP7 (matrix metallopeptidase 
7) have previously been reported as MCXCL4 markers [43]; our RNA-seq data showed their expression 
in MCXCL4 was highly variable among donors and was up–regulated in most other phenotypes, 
especially MIFNγ+LPS (Supplementary Tables 2 and 3). Given this low difference between MCXCL4 and 
unpolarised macrophage transcriptomes, we omitted MCXCL4 from further analysis (Figure 1C, 1D). 
Each MDM phenotype displayed significant enrichment of DEGs in atherosclerosis–related 
pathways (Supplementary Table 5). In most phenotypes, these pathways included genes clearly 
involved in macrophage lipid handling, such as ABCA1 (ATP binding cassette subfamily A member 
1), ABCG1 (ATP binding cassette subfamily G member 1), LPL (lipoprotein lipase) and MSR1 
(macrophage scavenger receptor 1) prompting further investigation into the lipid handling capacity of 
these phenotypes. The RNA-sequencing results were validated by qRT–PCR on parallel samples 
(Supplementary Figure 3), confirming differences in selected atherosclerosis-related genes. 
 
Reduced foam cell formation capacity in MIFNγ+LPS and MoxPAPC 
Our transcriptome analyses of macrophage phenotypes revealed differences in lipid handling and other 
associated pathway enrichment for differentially expressed genes (Supplementary Table 5). We 
therefore sought to assess foam cell formation capacity of the various polarised macrophages since 
this underlies the pathophysiology of atherosclerosis [44]. After loading with acLDL, we measured 



































































Area haematoxylin cells) in MIFNγ+LPS and MoxPAPC, while MIL–4 and MIL–10 showed an increase in foam 
cell formation, similar to that of unpolarised macrophages (Figures 2A & 2B).  
 
Reduced LDL uptake in MIFNγ+LPS 
Since MIFNγ+LPS and MoxPAPC showed reduced foam cell formation compared to other phenotypes, we 
assessed lipoprotein uptake, which impacts macrophage lipid handling and resultant foam cell 
formation [45]. We therefore measured fluorescently-labelled acLDL uptake in the different MDM 
phenotypes by flow cytometry. Analysis of MDMs exposed to AlexaFluor–488-conjugated acLDL 
showed significantly lower uptake in MIFNγ+LPS and non-significant reduction in MoxPAPC (p = 0.10). In 
contrast, MIL–4 and MIL–10 showed intracellular acLDL fluorescence levels similar to unpolarised 
macrophages (Figure 3A). Using reactome.org analysis, in MIFNγ+LPS we detected a global down–
regulation of ‘Ligand binding and uptake by scavenger receptors’ pathways (Figure 3B) and in key 
lipid uptake genes (Figure 3C), such as modified LDL receptors CD36 (cluster of differentiation 36) 
and MSR1 (macrophage scavenger receptor 1) [46,47]. This suggests that differential polarisation 
influences a transcriptional programme that affects downstream pathways regulating LDL uptake. In 
agreement with this, a reduction in both CD36 and MSR1 scavenger receptors was detected at the cell 
surface protein level in MIFNγ+LPS (Figure 3D). 
 
Cellular free cholesterol content in polarised macrophages after LDL loading 
In addition to lipid uptake, macrophage foam cell formation capacity is influenced by the ability of the 
cell to regulate its internal lipid content. Altering the balance of internal lipid processing and storage 
may result in changes in total, free and esterified cholesterol content in macrophage phenotypes. While 
IFNγ-treated macrophages have been shown to contain different levels of free cholesterol and its ester 
[48], the other phenotypes described in this study have not been assessed in this regard. We therefore 
measured the abundance of total, free and esterified cholesterol in control and acLDL–loaded cells to 
determine if intracellular cholesterol processing capacity affected differences in foam cell formation. 
 Unpolarised macrophages showed a larger change in total cholesterol (73.5 ± 19.7 ng 
cholesterol / ng protein), higher than for all polarisation-treated macrophage phenotypes (Figure 4A). 
MIFNγ+LPS exhibited no significant change in total cholesterol following loading (p = 0.10 for the 
difference between this condition and unpolarised cells, Figure 4A). We also calculated the cholesterol 
ester content, but did not observe statistically significant differences in cholesterol ester by phenotype, 
when compared to unpolarised macrophages (Figure 4B). Similar to the total cholesterol changes, 
MIFNγ+LPS showed no significant differences (p = 0.11) in the change of free cholesterol content (Figure 
4C).  
We examined the ‘LDL clearance’ pathway for DEGs according to MDM polarisation, to 
identify transcriptional differences in the cholesterol clearance pathways. In agreement with the 
cholesterol content determination, MIFNγ+LPS showed largely down–regulated expression of the entire 
clearance pathway (Figure 4D). Among key genes, SOAT1 was not differentially expressed in any 
phenotype, whereas, expression of NCEH1 was significantly reduced in MIFNγ+LPS (Figure 4E), in 
keeping with the cholesterol content assessment. In addition, LIPA (lipase A, lysosomal acid type, 
involved in lipoprotein particle breakdown) showed reduced expression in MIFNγ+LPS and increased in 
MIL–4, likely contributing to the differences in intracellular lipid handling between these phenotypes 
(Figure 4E). 
 



































































Lipid and cholesterol content are influenced by the cellular capacity for cholesterol efflux. 
Macrophages mainly unload intracellular lipid to apoliprotein AI (Apo–AI) via ABCA1 transporter 
while high–density lipoprotein (HDL) is capable of accepting lipid from ABCG1, SCARB1 (scavenger 
receptor class B member 1) [49] and other pathways. Previous reports indicated that pro-inflammatory 
macrophages had lower cholesterol efflux capacity [34] than anti-inflammatory macrophages [50]. We 
tested cholesterol efflux via both acceptors, 24 h after macrophage polarisation, to determine the 
reverse cholesterol transport capacity of each phenotype. 
Total TopFluor cholesterol efflux, involving both Apo–AI and HDL, was significantly reduced 
in MIFNγ+LPS while MIL–4 did not show a significantly altered efflux compared to unpolarised 
macrophages (Figure 5A). MIFNγ+LPS also showed a significantly lower capacity to efflux cholesterol 
regardless of whether HDL or Apo–AI was used as cholesterol acceptor (Figure 5B and C). MIL–4 
showed no significant difference in cholesterol efflux capacity in the presence of Apo–AI compared 
to unpolarised macrophages (Figure 5C). Following polarisation, expression of key active cholesterol 
efflux receptors ABCA1 and ABCG1 in ‘HDL assembly’ and ‘HDL remodelling’ pathways (Figure 
5D) showed an opposite pattern (Figure 6E) from the downstream functional data (Figure 5A–C). 
Expression of the major passive cholesterol efflux receptor SCARB1 (functions via HDL) was 
significantly lower in MIFNγ+LPS, but also uniquely increased in MIL–4 (Figure 5E), suggesting that 
expression of SCARB1 and the aforementioned ABC transporters are under different transcriptional 
regulation for lipid handling, post-polarisation. Protein levels of ABCA1 and ABCG1 upon MDM 
polarisation (Figure 5F) were similar to the cholesterol efflux capacities of each of the macrophage 
phenotypes (Figure 5A–C). SCARB1 cell–surface protein was uniquely up–regulated in MIL–4, 
matching our observations at the transcript level and further suggesting differences between regulation 





Macrophages polarise to a spectrum of phenotypes in response to their environment [24]. This 
systematic study compared human macrophage lipid handling capacities at the transcriptome, protein 
and functional levels for cells polarised towards factors relevant to the atherosclerotic plaque 
environment. Polarisation with IFNγ+LPS, IL–4, IL–10, oxPAPC and CXCL4 identified distinct 
transcriptional changes, MIFNγ+LPS being the most transcriptionally distinct phenotype in agreement 
with other related studies [51,52]. Transcriptional changes showed enrichment in atherosclerosis and 
lipid-associated pathways. Analysis of lipid processing activity showed MIL–4 and MIL–10 to have 
higher lipid uptake and foam cell formation activities, while inflammatory MIFNγ+LPS and MoxPAPC have 
lower foam cell activity. Functionally, there are key differences between the MIFNγ+LPS and MoxPAPC 
inflammatory macrophage phenotypes that account for their low foam cell formation: MIFNγ+LPS exhibit 
low lipid uptake while a higher lipid uptake in MoxPAPC is compensated by increased lipid efflux 
activity. 
 
Lipid handling by macrophages is clearly critical in atherogenesis. Thus, we also considered using 
lipids and lipoprotein particles as stimulating agents alone or in combination with the polarising factors 
we used to treat MDMs. However, our own pilot data (unpublished) and previous work has shown that 
lipid exposure of MDMs does not lead to notable transcriptomic changes or modify the impact of the 
polarising stimuli used in this study [52]. We therefore considered this as unlikely to provide additional 




































































While previous studies, and more frequently in murine models, have compared macrophage 
polarisation in response to specific stimuli, we undertook a systematic approach to directly compare 
the impact of IFNγ+LPS, IL–4, IL–10, oxPAPC and CXCL4 in human macrophages at the level of 
transcriptomes, protein through to functional lipid processing analysis. The analysis using 8 individual 
donors showed a clear distinction in transcriptional programming due to polarisation. All phenotypes 
showed a unique expression profile compared to unpolarised controls with exception of CXCL4 
polarisation, similar to work by Gleissner et al [42]. We noted that only a subset of the differentiated 
macrophages expressed CXCR3, the receptor for CXCL4, in all donors (46.3 ± 16.3 %). This may 
well have contributed to the minimal transcriptomic difference in this phenotype compared to 
unpolarised macrophages. Consistent with this, MMP7 and S100A8, which are considered markers for 
the CXCL4 phenotype [43], were not upregulated consistently in all donors, again suggesting 
incomplete polarisation. 
 
For the IFNγ+LPS, IL–4, IL–10 and oxPAPC polarisation conditions, the largest divergence in DEGs 
was between MIFNγ+LPS and MIL–4 polarisation, in keeping with other findings [51]. DEG enrichment 
in atherosclerosis and lipid associated IPA canonical pathways suggests a logical rationale for studying 
differences in lipid handling between macrophage phenotypes. 
 
The lipid handling capacities were similar for MIL–4, MIL–10 and unpolarised macrophages where each 
displayed efficient foam cell formation and acLDL uptake abilities alongside increased expression of 
MSR1, CD36, SOAT1, NCEH1, LIPA and other key genes in these scavenger receptor and LDL 
clearance pathways. At earlier stages of atherogenesis, MIL–4 and MIL–10 may prevent atherosclerosis 
progression by clearing lipid from within the artery wall due to their effective lipid processing capacity 
alongside effective efflux [4]. Our oil-red-O measurements showed high foam cell formation in these 
macrophages which may reflect a role in promoting atherosclerosis at later stages of disease where 
high levels of LDL and other lipids may overwhelm their capacity to process extracellular lipid[20,53]. 
The cholesterol transporter SCARB1 plays a role in both cholesterol efflux and influx[54]. At the 
protein level, SCARB1 was most highly expressed in MIL–4 compared to other polarisation states while 
ABCA1 and ABCG1 were significantly increased in both MIL–4 and MIL–10, but not to the same extent 
as SCARB1. It is likely that post-transcriptional regulation accounts for differences in all of these 
cholesterol transporters since protein changes were more pronounced and not always in the same 
direction to that of the mRNA levels. These findings suggest that SCARB1, in combination with 
MRC1, offers the potential as an additional marker for the MIL–4 phenotype given its level of 
upregulation. Increased SCARB1 in MIL–4 compared to MIFNγ+LPS likely accounts for their higher 
cholesterol efflux capacity. 
 
A pro-inflammatory and oxidised atherosclerotic plaque environment is associated with later stage 
disease, plaque instability and vulnerability to rupture [31]. Infection is a risk factor for myocardial 
infarction[55]while LPS has been detected within human plaques[56]. MIFNγ+LPS and MoxPAPC 
phenotypes can arise due to differences in sterile inflammatory stimuli where the effect of oxidised 
phospholipids on macrophage lipid metabolism is less well understood, particularly in human 
macrophages. Oxidised phospholipids, derived from oxidation of lipoproteins and apoptotic cell 
membranes, induce TLR2-mediated acute inflammatory responses in macrophages [57]. Some reports 
of MoxPAPC polarised mouse macrophages have shown that the phagocytic activity of these 



































































uptake and processing, similar to the levels observed in MIL–4 and MIL–10 macrophages. At the same 
time, MoxPAPC showed low foam cell formation, which is likely accounted for by their high capacity to 
efflux cholesterol. MoxPAPC showed lower expression of ABCG1 and SCARB1 compared to MIL–4 and 
MIL–10 suggesting that efflux may be coupled to other transporters or they can process lipids more 
efficiently due to other regulatory factors. In contrast, MIFNγ+LPS showed lower acLDL uptake 
compared to other phenotypes, accompanied by low foam cell formation. 
 
Atherosclerosis associated macrophage polarisation dramatically affects the cell’s capacity to handle 
lipid. Whole transcriptome sequencing of differentially polarised macrophages revealed distinct 
phenotypes where differences in key lipid handling gene and protein levels have a lasting effect on 
downstream lipid handling, as observed by differences in LDL uptake, cellular cholesterol levels and 
the capacity to efflux excess cellular cholesterol. Functional differences account for low foam cell 
formation in differentially polarised inflammatory macrophages: MIFNγ+LPS exhibit low lipid uptake 
while increased lipid uptake in MoxPAPC is matched by increased lipid efflux activity. All of these 
processes influence the formation of lipid–laden macrophage foam cells, underlying the progression 
of atherosclerosis and vulnerability to cardiovascular disease. 
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Figure 1: Global analyses of human macrophage phenotype transcriptomes. 
Human monocyte-derived macrophages from 8 donors were polarised with IFNγ+LPS, IL–4, IL–10, 
oxPAPC or CXCL4 and examined by RNA–seq for global and specific pathway changes in their 
transcriptomes. (A) Principal component analysis (PCA) and (B) numbers of differentially expressed 
genes (|log2FC| > log2(1.5) and FDR < 0.05 (Benjamini and Hochberg method)) among all conditions. 
(C) Principal component analysis (PCA) and (D) numbers of differentially expressed genes excluding 
MCXCL4. PC – principal component, DEG – differentially expressed gene. 
 
Figure 2: Foam cell formation capacity by macrophage phenotypes. 
(A) Representative Oil–Red–O staining of control and acLDL (25µg/ml for 24 h) loaded human 
monocyte-derived macrophages displaying presence of foam cells. Red arrow indicates positive Oil-
Red-O staining where % control – % acLDL–loaded Area ORO > Area haematoxylin, scale bars = 100 μm. 
(B) Quantification of foam cell formation capacity of human monocyte-derived macrophages, 
unpolarised (Mun), or polarised with IFNγ+LPS, IL–4, IL–10 or oxPAPC, determined using Image J 
polygonal seletion and area measurements, where foam cells were considered positive for oil-red-O 
staining greater than the area of the nucleus. Δ% foam cells = control % foam cells – acLDL % foam 
cells; mean ± SEM, n = 5 separate donors, matched/repeated measures one–way ANOVA with 
Dunnett’s post–hoc test, ** p ≤ 0.01 compared to Mun. 
 
Figure 3: LDL uptake by macrophage phenotypes. 
(A) Flow cytometry quantification of AlexaFluor–488–acLDL internalisation by human monocyte-
derived macrophages, (Mun), or polarised with IFNγ+LPS, IL–4, IL–10 or oxPAPC, n = 8. (B) 
Differentially expressed mRNAs in the ‘Binding and uptake of ligands by scavenger receptors’ 
pathway using reactome.org analysis (annotations retrieved from reactome.org on 16 October 2018) 
in Mx compared to unpolarised (Mun) measured using RNA–seq; n = 8, thresholds for differential gene 
expression were |log2FC| > log2(1.5) and FDR < 0.05 (Benjamini and Hochberg method). RNA–seq. 
(C) MSR1 and CD36 mRNA expression among MDM phenotypes relative to unpolarised (Mun); n = 
8 donors, dotted lines = |log2(1.5)|, *** FDR ≤ 0.001. (D) Flow cytometry quantification of MSR1 and 
CD36 cell surface protein levels by MDM phenotypes, n = 5. (A and D) Mean ± SEM, 
matched/repeated measures one–way ANOVA with Dunnett’s post-hoc test, * p < 0.05, *** p ≤ 0.001, 
compared to Mun. MFI – geometric mean fluorescence intensity. 
 
Figure 4: Internal lipid content and lipoprotein processing in macrophage phenotypes. 
Colorimetric quantification of change in (A) total cholesterol, (B) cholesterol ester and (C) free 
cholesterol; mean ± SEM, n = 4 donors, matched/repeated measures one–way ANOVA with Dunnett’s 
post–hoc test, by human monocyte-derived macrophages polarised with IFNγ+LPS, IL–4, IL–10 or 
oxPAPC compared to unpolarised (Mun). (D) Differentially expressed mRNAs in the ‘LDL clearance’ 
pathway (annotations retrieved from reactome.org on 16 October 2018) of Mx compared to Mun 
measured using RNA–seq; n = 8, thresholds for differential gene expression were |log2FC| > log2(1.5) 
and FDR < 0.05 (Benjamini and Hochberg method). (E) RNA–seq quantification of SOAT1, NCEH1, 
LIPA mRNA expression among MDM phenotypes compared to Mun, n = 8, dotted lines = |log2(1.5)|, 
* FDR < 0.05, ** FDR ≤ 0.01, *** FDR ≤ 0.001. 
 



































































Fluorescence quantification of MDM cholesterol efflux for total cholesterol (A) via both lipid 
acceptors, HDL (B) and Apo–AI (C) separately; mean ± SEM, n = 4 donors, matched/repeated 
measures one–way ANOVA with Dunnett’s post–hoc test, ** p ≤ 0.01, *** p ≤ 0.001 by human 
monocyte-derived macrophages polarised with IFNγ+LPS, IL–4, IL–10 or oxPAPC compared to 
unpolarised (Mun). (D) Differentially expressed genes in the ‘HDL assembly’ and ‘HDL remodelling’ 
pathways (annotations retrieved from reactome.org on 16 October 2018) in Mx compared to Mun 
measured using RNA–seq; n = 8 donors, thresholds for differential gene expression were |log2FC| > 
log2(1.5) and FDR < 0.05 (Benjamini and Hochberg method). (E) RNA–seq quantification of ABCA1, 
ABCG1, SCARB1 mRNA expression among MDM phenotypes compared to Mun, n = 8 donors, dotted 
lines = |log2(1.5)|, ** FDR ≤ 0.01, *** FDR ≤ 0.001. (F) Flow cytometry quantification of MDM 
phenotype for ABCA1 (n = 5), ABCG1 (n = 6) and SCARB1 (n = 4 donors) cell surface protein levels; 
mean ± SEM, matched/repeated measures one–way ANOVA with Dunnett’s post–hoc test, * p < 0.05, 
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